CLASS II Drug recall · Reported 19 Jul 2023 · FDA Enforcement Report

Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg recalled

L. Perrigo is recalling Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, distributed nationwide in the US. The recall was initiated on 9 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 2DV1925, Exp. date 06/23
Quantity recalled16,200 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0903-2023
FDA event ID
91672
Recalling firm
L. Perrigo, Allegan, MI
Classification
Class II
Status
Terminated
Recall initiated
9 Feb 2023
FDA classified
11 Jul 2023
Reported
19 Jul 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

9 Feb 2023Recall initiated by company
11 Jul 2023Classified by FDA+152 days
19 Jul 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39

Where it was distributed

Nationwide within the USA

Nationwide

Stores named: CVS

Questions about this recall

Is Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg recalled?

Yes. L. Perrigo recalled Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg on 9 Feb 2023. The recall is Class II and its status is Terminated. Recall number D-0903-2023.

Why was it recalled?

Failed Impurities/Degradation Specifications

Which lots are affected?

Lot #: 2DV1925, Exp. date 06/23

Where was it sold?

Nationwide within the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from L. Perrigo

All 28
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIaller-ease, Fexofenadine Hydrochloride Tablets, 180 mg recalledExchange Select Aller EaseL. PerrigoPotency & AssayNationwide
DrugCLASS IIAllergy Aller-fex, Fexofenadine Hydrochloride Tablets, 180 mg recalledKirkland Signature Aller FexL. PerrigoPotency & AssayNationwide
DrugCLASS IINon-Drowsy Allergy Relief, Fexofenadine Hydrochloride recalledBerkley Jensen Allergy ReliefL. PerrigoPotency & AssayNationwide
DrugCLASS IIAllergy, Fexofenadine Hydrochloride Tablets, 180 mg recalledBasic Care AllergyL. PerrigoPotency & AssayNationwide
DrugCLASS IIPicnic, Fexofenadine Hydrochloride Tablets, 180 mg, Antihistamine recalledL. PerrigoPotency & AssayNationwide